Nicole Vitullo, Director at Esperion Therapeutics, Inc. (ESPR), sold 13,629 shares at $44.66 ($609K) on 2019-03-19, disclosed to the SEC on 2019-03-21.
Open-market sale of $609k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |